Welcome to our dedicated page for Ducommun Del SEC filings (Ticker: DCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ducommun Incorporated SEC filings document the aerospace and defense manufacturer’s operating results, governance actions, capital structure and material events. The company reports results for its Electronic Systems and Structural Systems businesses, with disclosures tied to commercial aircraft platforms, military and space programs, and industrial applications.
Ducommun filings include Form 8-K reports on earnings releases, Regulation FD matters, material agreements, credit facilities and legal settlements. Proxy and annual meeting disclosures cover director elections, executive compensation votes, auditor ratification, stock incentive plan matters and shareholder voting results. The filings also identify the company’s common stock as NYSE-listed under the symbol DCO.
Ducommun Inc. executive Laureen S. Gonzalez, the company’s Vice President and Chief Human Resources Officer, sold 589 shares of common stock in an open-market transaction at $151.99 per share. The filing states that all shares were sold at this exact price.
According to the disclosure, the sale was carried out to satisfy Gonzalez’s obligations under Ducommun’s Second Amended and Restated Clawback Policy, following a restatement and revision of previously issued financial statements. The proceeds from this transaction will be applied to those clawback obligations, and Gonzalez now directly holds 11,172 shares of common stock.
Ducommun Inc. Chairman, President & CEO Stephen G. Oswald reported a bona fide gift of 2,034 shares of Common Stock on May 28, 2026 at no stated price. After this charitable transfer, he directly holds 387,795 Ducommun shares, indicating the gift is small relative to his remaining stake.
Strycker Samara A reported acquisition or exercise transactions in this Form 4 filing.
Ducommun Inc. director Samara A. Strycker received a grant of 1,200 shares of common stock on May 27, 2026. The award was recorded at a price of $0.00 per share, reflecting a compensation-related grant rather than a market purchase. Following this grant, Strycker directly holds 10,700 shares of Ducommun common stock.
Kramer Sheila G. reported acquisition or exercise transactions in this Form 4 filing.
Ducommun Inc. director Sheila G. Kramer received an equity grant of 1,200 shares of Common Stock on May 27, 2026 at a stated price of $0.0000 per share. Following this award, she directly holds 11,700 shares of Ducommun common stock.
Ducommun Inc. director Daniel G. Korte reported an indirect acquisition of 1,200 shares of Ducommun common stock on May 27, 2026. The shares were received at no cost as a grant or award and are held in a trust for the benefit of his family. Following this transaction, the trust holds a total of 4,311 Ducommun shares.
Drazba Shirley reported acquisition or exercise transactions in this Form 4 filing.
Ducommun Inc. director Shirley Drazba received a grant of 1,200 shares of Common Stock. The shares were awarded at a reported price of $0.00 per share, indicating a compensation-related stock award rather than an open-market purchase. Following this grant, Drazba directly holds 18,140 shares of Ducommun common stock.
DUCOMMUN INC /DE/ director Mark A. Caylor received a grant of 1,200 shares of Common Stock. The shares were acquired on May 27, 2026 at a stated price of $0.00 per share, bringing his directly held position to 1,200 shares. This appears to be a compensation-related equity award rather than an open-market purchase.
Carter David B. reported acquisition or exercise transactions in this Form 4 filing.
Ducommun Inc. director David B. Carter received a grant of 1,200 shares of common stock on May 27, 2026. The shares were awarded at a stated price of $0.00 per share, indicating a compensation-related grant rather than a market purchase. Following this award, Carter directly holds 6,900 shares of Ducommun common stock.
BOEHLE DANIEL L. reported acquisition or exercise transactions in this Form 4 filing.
Ducommun Inc. director Daniel L. Boehle received a grant of 1,200 shares of Common Stock on May 27, 2026 at no purchase price. Following this award, he directly holds a total of 4,311 Ducommun common shares.
DCO submission of a Form 144 notice lists proposed sales of restricted common stock held by an issuer-directed broker account. The filing records two restricted-stock lots: 290 shares dated 05/08/2025 and 299 shares dated 05/14/2025.
The cover lines show the broker as Morgan Stanley Smith Barney LLC Executive Financial Services and a filing reference date of 05/28/2026. No proceeds, prices, or purchaser details are shown in the excerpt.